Wat is de prijs voor QuantRx Biomedical Corporation (QTXB)

Het prijs van QuantRx Biomedical Corporation (QTXB) is $0.0005

Wat is de marktkapitalisatie voor QuantRx Biomedical Corporation (QTXB)

Marktkapitalisatie voorQuantRx Biomedical Corporation (QTXB) is $118.05K

QuantRx Biomedical Corporation (QTXB) Winst

QuantRx Biomedical Corporation is engaged in the creation and marketing of its patented miniature pads (PADs) and related over-the-counter (OTC) products within the United States. Additionally, the company is developing genomic diagnostic tools for the laboratory market, leveraging its proprietary lateral flow technologies, including the RapidSense single-step lateral flow test. The company's PAD products are designed to address a range of medical conditions such as hemorrhoids, mild vaginal infections, urinary incontinence, menstrual hygiene, and other general medical needs. Key offerings include InSync, an interlabial pad for feminine hygiene. Another significant product is the Unique miniform, which comes in two forms: a medicated pad providing temporary relief from the itching and discomfort associated with hemorrhoids and minor vaginal infections, and an unmedicated pad for daily management of light urinary, vaginal, or anal leakage. Other treated miniform products are also part of their portfolio. Established in 1986, QuantRx Biomedical Corporation is headquartered in Tualatin, Oregon.

Jaar	Winst	Wijzigen
Niet genoeg gegevens voor de verstrekte datums.

Jaar

Winst

Wijzigen

Niet genoeg gegevens voor de verstrekte datums.

Bedrijf	Winst	Winstverschil	Land
Intuitive Surgical, Inc. ISRG.US	$3.81B	-	US
EssilorLuxottica S.A. EL.PA	$4.11B	-	FR
HOYA Corporation 7741.T	-	-	JP
Becton, Dickinson and Company BDX.US	$1.59B	-	US
Alcon Inc. ALC.SW	-	-	CH

Bedrijf

Winst

Winstverschil

Land